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Abstract
Background
Socioeconomic disadvantage (SED) has been consistently associated with early life mental
health problems. SED has been shown to impact multiple biological systems, including the
regulation of neurotrophic proteins, immune-inflammatory and oxidative stress markers,
which, conversely, have been reported to be relevant to physiological and pathological neu-
rodevelopment This study investigated the relationship between SED, different domains of
psychopathology, serum levels of interleukin-6 (IL6), thiobarbituric acid-reactive substance
(TBARS) and brain-derived neurotrophic factor (BDNF). We hypothesized that a composite
of socioeconomic risk would be associated with psychopathology and altered levels of
peripheral biomarkers. In addition, we hypothesized that SED would moderate the associa-
tions between mental health problems, IL6, TBARS and BDNF.
Methods and Findings
Using a cross-sectional design, we measured the serum levels of IL6, TBARS and BDNF in
495 children aged 6 to 12. We also investigated socio-demographic characteristics and
mental health problems using the Child Behaviour Checklist (CBCL) DSM-oriented scales.
SED was evaluated using a cumulative risk model. Generalized linear models were used to
assess associations between SED, biomarkers levels and psychopathology. SED was sig-
nificantly associated with serum levels of IL6 (RR = 1.026, 95% CI 1.004; 1.049, p = 0.020)
and TBARS (RR = 1.077, 95% CI 1.028; 1.127, p = 0.002). The association between SED
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and BDNF was not statistically significant (RR = 1.031, 95% CI 0.997; 1.066, p = 0.077).
SED was also significantly associated with all CBCL DSM-oriented scales (all p < 0.05),
whereas serum biomarkers (i.e. IL6, TBARS, BDNF) were associated with specific sub-
scales. Moreover, the associations between serum biomarkers and domains of psychopa-
thology were moderated by SED, with stronger correlations between mental health
problems, IL6, TBARS, and BDNF being observed in children with high SED.
Conclusions
In children, SED is highly associated with mental health problems. Our findings suggest that
this association may be moderated via effects on multiple interacting neurobiological
systems.
Introduction
In children and adolescents, mental health problems are highly prevalent, debilitating and one
of the main predictors of adult mental disorders [1–5]. It is well established that childhood psy-
chopathology emerges in the context of an intricate relation between genetic and environmen-
tal risk factors [6–8]. Among these environmental risk factors, socioeconomic disadvantage
(SED) has been described as one of the major contributors for the development and persistence
of mental health problems [9–13]. Epidemiological and clinical evidence indicates that SED is
associated with multiple dimensions of psychopathology, with more robust effects on external-
izing problems, such as aggressive and delinquent behaviors, and a less robust, but still signifi-
cant, association with internalizing symptoms, such as anxiety and depression [10–12, 14].
Several mechanisms have been proposed to explain the effects of SED on psychopathology.
Low socioeconomic position is often associated with material deprivation, as well as with resi-
dence in neighborhoods where crime and substance abuse tend to be more prevalent; and edu-
cational/economic opportunities less available [15–17]. Exposure to chronic stress, frequently,
but not exclusively, related to the experience of “social defeat”, or the experience of being
excluded or isolated, has also been conceptualized as key factor [18, 19]. More recently, an
association between SED and the neural substrates of psychopathology has been highlighted.
Neuroimaging studies have reported and association between SED and alterations in brain
structure and function, characterized, for example, by a decreased volume in the prefrontal
cortex and its subdivisions (e.g. orbitofrontal cortex, anterior cingulate cortex), areas promi-
nently involved in cognitive and emotional processing [13, 20–22]. Longitudinal studies have
documented that SED was associated with divergent neurodevelopmental trajectories, with
children from low socioeconomic background having slower gray matter growth during child-
hood [23, 24].
From a molecular perspective, neurotrophic proteins, immune-inflammatory and oxidative
stress markers have been consistently reported to be associated with brain structure and func-
tion and to be relevant to physiological and pathological neurodevelopment [25, 26]. Associa-
tions between alterations in these systems have been reliably described in children and adults,
across disparate mental disorders [27–32]. Moreover, convergent evidence indicates that early
life SED is independently and strongly associated with inflammation in children [33], as well as
prospectively in adults [34–37]. Conversely, serum levels of brain-derived neurotrophic factor
(BDNF) and functional variations of the BDNF gene were also shown to be affected by SED
[38, 39].
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We recently demonstrated that SED is associated with general psychopathology, indepen-
dently from co-occurring risk factors (i.e. parental mental disorders, perinatal complications)
(Mansur et al., unpublished data). Moreover, we also documented that exposure to environ-
mental risk factors moderates the association between IL6 and general psychopathology [40].
However, the association between peripheral biomarkers and mental health problems is not
completely understood, especially regarding the factors that mediate and/or moderate this rela-
tionship. Considering that SED could potentially impact the neural systems that underlie psy-
chopathology, as well modulate systemic adaptations (e.g. immune and endocrine changes), it
is possible that this factor could, at least partially, explain the association between SED and dif-
ferent domains of psychopathology. Herein we sought to extend results from these previous
studies by evaluating the impact of SED on serum IL6, BDNF and the marker of lipid peroxida-
tion thiobarbituric acid-reactive substance (TBARS). We also aimed to assess the impact of
SED on the association between biomarkers and dimension of psychopathology. We hypothe-
sized that (1) SED would be associated with altered levels of IL6, TBARS and BDNF levels; and
(2) SED would moderate the association between biomarkers and psychopathology, wherein
the correlation between biomarkers and dimensions of psychopathology would be stronger in
children with exposure to high SED.
Methods
Participants
The sample herein is part of the High Risk Cohort Study for Psychiatric Disorders Study,
which has been reported elsewhere [41]. From the total cohort of 2,512 subjects, 1,004 children
were invited to participate in enriched imaging/biomarker cohort. A total of 741 subjects com-
pleted the imaging procedures and 495 children provided valid blood samples for the study
herein. Primary reasons for missing blood samples were: caregiver refusal, children refusal and
technical complications during blood processing procedures. Written informed consent was
provided by all parents of participants, and verbal consent was obtained from all children. The
study was approved by the Ethics Committee of the Universidade de São Paulo (IORG00048
84). All families were invited for an appointment with a trained psychologist and social worker
in case they were interested in receiving the results of the study evaluation. All children identi-
fied as being under the need of care were referred for clinical evaluation. Situations involving
serious risk of physical or psychological harm received special attention in accordance to com-
petent authorities’ guidelines.
Measurements
Environmental risk factors. Questions about risk factors were determined after a critical
review of the extant literature that has primarily reported on risk factors for mental disorders
[41] and included inquiries about demographic and social factors (e.g. socio-economic status,
parental education). We created a cumulative risk index, conceptualized as each individual’s
cumulative exposure to a set of indicators of SED, according to previous studies [42–46]. Defi-
nitions and descriptive statistics of risk factors indicators are reported in Table 1. Each indica-
tor was weighted equally and summed. For analyses of interaction we created a dichotomous
variable for high exposure, defined as exposure to 2 or more indicators of SED.
Child Behavior Checklist (CBCL). Psychopathology was assessed dimensionally; using
the CBCL, which is a parent-report questionnaire that assesses various behavioral and emo-
tional problems. The CBCL is a widely used standardized measure of maladaptive behavior
and emotional complications in individuals between ages 4 and 18 [47, 48]. For the study
herein, we used the DSM-oriented scales (i.e. depressive problems, anxiety problems, somatic
Socioeconomic Disadvantage, Biomarkers and Psychopathology
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problems, attention deficit/hyperactivity problems, oppositional defiant problems and conduct
problems), which have good validity and clinical usefulness [49, 50].
Blood samples collection and biomarkers assessment. Whole blood samples were
obtained from all children. All samples were obtained between 10:00am and 4:00pm. After col-
lection, blood was allowed to clot by leaving it undisturbed at room temperature and then
serum extracted after blood had been processed at 1,000–2,000 x g for 10 minutes in a refriger-
ated centrifuge. Serum was kept at −80°C until further analyzed. As the samples were labeled
with numbers, without any group identification, the investigators were blinded for all
procedures.
BDNF serum levels were measured with sandwich-ELISA, using a commercial kit according
to the manufacturer's instructions (Milipore, USA). For assessment of oxidative stress, serum
levels of malondialdehyde (MDA), a product of lipid peroxidation, were measured by the
TBARS (thiobarbituric acid reactive substances) method [51]. Serum IL6 levels were measured
by flow cytometry using the Cytometric Bead Array (CBA) Flex Set Kit (BD Biosciences, San
Jose, CA) (Cat. #558276). Acquisition was performed with a FACSCanto II flow cytometer
(BD Biosciences, San Jose, CA). The instrument has been checked for sensitivity and overall
performance with Cytometer Setup and Tracking beads (BD Biosciences) prior to data acquisi-
tion. Quantitative results were generated using FCAP Array v1.0.1 software (Soft Flow Inc.,
Pecs, Hungary).
Statistical analyses
All statistical analyses were conducted using SPSS software for Windows (version 23.0). For
the comparison of demographic and clinical data, the independent samples t-test was used for
quantitative variables; the Chi-square test was used for categorical variables. Generalized linear
models were used to assess associations between SED, biomarkers levels and psychopathology.
We used linear, Poisson (for count data, e.g. CBCL scales) and gamma (for positively skewed
distribution, e.g. serum TBARS and IL6 levels) distributions, as appropriate. Interactions
between SED and biomarkers were assessed by adding the product term (i.e. SEDIL6) to the
tested models. Due to the non-linearity of the models, the estimated β coefficients were trans-
formed into rate ratio (RR) estimates. Post hoc correction to control for the false discovery rate
was applied according to the Benjamini Hochberg procedure [52].
Results
Sample characteristics
The mean age was 10.06 years (SD 1.88) (males 9.94 years, SD 1.91; females 10.19 years, SD
1.85). 45.1% of the study population were female and 58% of the study population were
Table 1. Definitions and descriptive statistics.
Socioeconomic Disadvantage Index
Label Definition n, %
1. Social Welfare Receiving governmental social assistance (e.g. Bolsa Família
[Family Allowance])
113
(22.8%)
2. Low Income Income from both parents in the lower 25thpercentile of the
sample
115
(23.2%)
3. Single Parent Living in a single-parent household 110
(22.2%)
4. Unemployment Having at least 1 parent who is currently unemployed 48 (9.7%)
5. Low Educational
Achievement
Both parents with incomplete primary education 45 (9.1%)
doi:10.1371/journal.pone.0160455.t001
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Caucasian. SED index range was 0–5 and the median was 2.0 (SD 1.05); 263 (53.1%) children
were classified as high exposure (i.e. exposed to 2 or more social indicators). Twenty-eight chil-
dren (5.7%) were not exposed to any SED factor, 204 children (41.2%) were exposed to 1 SED
factor, 152 children (30.7%) were exposed to 2, 77 (15.6%) were exposed to 3, 27 (5.5%) were
exposed to 4; and 7 (1.4%) were exposed to 5 SED factors. No significant correlation was found
between the SED index and, respectively, age (r = 0.043, p = 0.339), gender (p = 0.826) or eth-
nicity (p = 0.644). There was also no association between the binary indicator of high SED and
age (p = 0.532), gender (p = 0.925) and ethnicity (p = 0.650).
Means, SDs and ranges for the CBCL DSM-oriented scales were, respectively: depressive
problems 4.43, 4.16, 0–22; anxiety problems 3.84, 2.63, 0–11; somatic problems 2.11, 2.08,
0–11; attention deficit/hyperactivity problems 5.86, 3.82, 0–14; oppositional defiant problems
3.98, 2.81, 0–10; and conduct problems 3.42. 4.20, 0–20. As for specific diagnosis, 76 children
(15.4%) were diagnosed with an anxiety disorder, 25 (5.1%) with a mood disorder, 61 (12.3%)
with attention deficit/hyperactivity disorder, 38 (7.7%) with oppositional/conduct disorders, 3
(0.6%) with tic disorders and 4 (0.8%) with eating disorders).
Socioeconomic disadvantage and peripheral biomarkers
Serum IL6 median was 2.58 pg/ml (interquartile range [IQR] 2.22–2.91), TBARS median was
14.04 pg/ml (IQR 9.63–21.72) and BDNF median was 26.04 pg/ml (IQR 20.12–33.54). There
was no correlation between age, IL6 (r = 0.059, p = 0.190), TBARS (r = -0.016, p = 0.723) and
BDNF levels (r = 0.065, p = 0.151). There was also no effect of ethnicity (p = 0.058, p = 0.708,
p = 0.537, respectively); BDNF levels were higher in female participants (p = 0.002), but no
effect of gender were observed on serum IL6 (p = 0.060) or TBARS (p = 0.695).
There was a positive correlation between the SED index, serum IL6 (r = 0.121, p = 0.007),
TBARS (r = 0.145; p = 0.001) and BDNF levels (r = 0.098, p = 0.022). After adjustments for
age, gender and ethnicity, the association between SED, IL6 (RR = 1.026, 95% CI 1.004; 1.049,
p = 0.020) and TBARS remained significant (RR = 1.077, 95% CI 1.028; 1.127, p = 0.002),
whereas there was a trend for BDNF (RR = 1.031, 95% CI 0.997; 1.066, p = 0.077).
Socioeconomic disadvantage, peripheral biomarkers and
psychopathology
Table 2 shows that SED was positively associated with all CBCL scales when analyzed sepa-
rately (Model 1) and together with the biomarkers (Model 2). The biomarkers had somewhat
distinct patterns of associations with the different scales, with IL6 being more strongly associ-
ated with scores on the depressive and anxiety scales; and TBARS being associated with the
anxiety and conduct scales. BDNF was only associated with the anxiety, attention and conduct
scales when analyzed separately.
Interaction analyses indicated a significantly positive interaction between high SED and
BDNF on depressive problems, indicating that a positive correlation between BDNF and
depressive problems was only positive in the children from the high SED group (Fig 1). The
moderating effect of SED on the association between BDNF and psychopathology was specific
to depressive problems, as the results were non-significant for measures on other scales
(Table 3). Moderating effects on IL6 and TBARS were, on the other hand, pleiotropic, as it was
significant in almost all subscales, with the only exceptions being depressive and oppositional
defiant problems, for IL6, and somatic problems, for TBARS (Table 3). All of the significant
interactive effects with IL6 and TBARS were positive, indicating a stronger correlation between
biomarkers and psychopathology in children from the high SED group, compared to children
in the low SED group (Fig 1).
Socioeconomic Disadvantage, Biomarkers and Psychopathology
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Discussion
Our results indicate that SED is robustly associated with multiple domains of psychopathology.
The strongest association in our sample was with conduct problems; an association with anxi-
ety symptomatology was also significant [11, 53]. Evidence indicates that familial context (i.e.
parents educational level or occupational status) and residence in deprived neighborhoods,
with more exposure to deviant peer behavior and lower social support, are more related to
externalizing problems [54, 55]. Internalizing symptoms, on contrast, would be more, but not
exclusively, associated with individual temperament and genetic vulnerabilities [12, 56].
Serum biomarkers also had differential associations with mental health problems, with the
inflammatory cytokine IL6 being more strongly associated with the internalizing dimension
(i.e. depressive, anxiety and somatic problems) and the oxidative stress marker TBARS with
Table 2. Associations between socioeconomic disadvantage, IL6, TBARS and BDNF; considered separately (Model 1) and together (Model 2). All
analyses included age, gender and ethnicity as covariates.
Model 1 Model 2
RR 95% CI Adj. p-value* RR 95% CI Adj. p-value*
Depressive Problems
SED 1.118 1.080; 1.158 < 0.001 1.120 1.077; 1.164 0.004
IL6 1.133 1.075; 1.194 0.005 1.142 1.080; 1.208 < 0.001
TBARS 1.003 0.999; 1.008 0.242 1.000 0.996; 1.005 0.965
BDNF 1.002 0.998; 1.006 0.392 0.999 0.995; 1.004 0.761
Anxiety Problems
SED 1.007 1.033; 1.123 0.002 1.060 1.016; 1.106 0.018
IL6 1.145 1.081; 1.213 < 0.001 1.125 1.060; 1.194 < 0.001
TBARS 1.007 1.002; 1.012 0.012 1.005 1.001; 1.010 0.074
BDNF 1.005 1.001; 1.011 0.044 1.003 0.998; 1.008 0.282
Somatic Problems
SED 1.081 1.022; 1.143 0.016 1.063 1.005; 1.126 0.057
IL6 1.125 1.038; 1.219 0.012 1.103 1.015; 1.198 0.037
TBARS 1.008 1.002; 1.015 0.022 1.006 0.999; 1.013 0.089
BDNF 1.004 0.998; 1.010 0.282 1.002 0.995; 1.008 0.681
Attention Deficit/Hyperactivity Problems
SED 1.099 1.062; 1.136 0.004 1.089 1.052; 1.126 0.003
IL6 1.067 1.017; 1.120 0.019 1.043 0.991; 1.097 0.152
TBARS 1.005 1.001; 1.009 0.021 1.003 0.999; 1.007 0.146
BDNF 1.005 1.001; 1.008 0.032 1.003 0.999; 1.007 0.179
Oppositional Defiant Problems
SED 1.094 1.050; 1.140 < 0.001 1.085 1.041; 1.131 < 0.001
IL6 1.061 1.000; 1.126 0.080 1.043 0.981; 1.109 0.236
TBARS 1.006 1.002; 1.011 0.019 1.005 1.000; 1.009 0.089
BDNF 1.002 0.998; 1.007 0.392 1.001 0.996; 1.005 0.844
Conduct Problems
SED 1.289 1.237; 1.343 < 0.001 1.276 1.223; 1.330 < 0.001
IL6 1.061 0.995; 1.132 0.108 1.004 0.937; 1.077 0.915
TBARS 1.011 1.006; 1.016 < 0.001 1.007 1.002; 1.012 0.002
BDNF 1.006 1.002; 1.011 0.019 1.003 0.999; 1.008 0.224
* Adj. p-value: Benjamini Hochberg post hoc corrected p-value.
RR: rate ratio; CI: confidence interval; SED: socioeconomic disadvantage, IL6: interlukin-6; TBARS: thiobarbituric acid-reactive substance; BDNF: brain-
derived neurotrophic factor.
doi:10.1371/journal.pone.0160455.t002
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externalizing symptoms (i.e. attentional, oppositional and conduct problems). The neurotro-
phin BDNF had, in comparison, weaker associations, especially in the models that analyzed all
the variables together. Effect sizes were relatively small, although were largely consistent with
previous mechanistic studies [29, 33]. Considering the complexity of mental illnesses etiology,
which involves multiple interacting genetic, environmental and biological factors; large effect
Fig 1. Mental health problems and peripheral biomarkers within socioeconomic disadvantage
exposure subgroups.Correlations between (A) somatic problems and serum IL6; (B) attention deficit/
hyperactivity problems and serum TBARS and (C) depressive problems and serum BDNF; within
socioeconomic disadvantage exposure subgroups. SED: socioeconomic disadvantage; IL6: interlukin-6;
TBARS: thiobarbituric acid-reactive substance; BDNF: brain-derived neurotrophic factor.
doi:10.1371/journal.pone.0160455.g001
Socioeconomic Disadvantage, Biomarkers and Psychopathology
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sizes are unlikely to be detected; therefore the magnitude of the associations described in this
community-based study are noteworthy and possibly indicative of clinical relevance.
Evidence on putative specific effects of different pathophysiological pathways is scarce.
There are reports of positive correlations between plasma markers of oxidative stress and atten-
tion deficit hyperactivity disorder, as well as aggressive behavior in adults [57, 58]. Oxidative
stress induces damage to nucleic acids or lipids, which has the potential to impair basic cellu-
lar/neuronal functions [59]. Indeed, there is evidence that lipid peroxidation is associated with
white matter damage, which could potentially affect the circuits that regulate aggressive/con-
frontational behavior [60, 61]. Consistent with our results, alterations in inflammatory mark-
ers, including an increase in serum IL6, have been observed in children and adolescents with
major depressive disorder [32]. The relationship between inflammation and mood has been
extensively studied, with potential mechanisms including, but not limited to, effects on mono-
amine levels through activation of indoleamine 2,3-dioxygenase (IDO), which degrades trypto-
phan, and pathologic microglial cell activation [62, 63].
Peripheral biomarkers were positively correlated with SED, with higher levels of IL6,
TBARS and BDNF being found in children with low socioeconomic position. As hypothesized,
SED moderated the association between IL6, TBARS, BDNF and domains of psychopathology.
All significant interactions were in the same direction, with a stronger association between
peripheral markers and mental health problems in children exposed to high SED. Interestingly,
we observed an interaction between SED and BDNF on depressive problems, even though
there was no significant association between BDNF and depressive symptoms, indicating that
BDNF’s relationship with this domain of psychopathology may be fully dependent of socioeco-
nomic position. Associations between IL6 and internalizing problems, as well as between
TBARS and externalizing symptoms, were also modified by the presence of SED. These results
indicate that the differential effects of SED on each domain of psychopathology may be sub-
served by differential activations of neurobiological pathways.
Conceptually, the accumulation of multiple adverse conditions (e.g. SED) may lead to sev-
eral different types of emotional or behavioral outcomes, which has been termed multifinality
[64]. This model has been empirically supported [53, 65, 66]; nonetheless, there is evidence
that specific developmental trajectories are more likely than others. For example, some
Table 3. Effects of interactions between high socioeconomic disadvantage and peripheral biomarkers on CBCL scales. All analyses included age,
gender and ethnicity as covariates.
RR 95% CI Adj. p-value* RR 95% CI Adj. p-value*
Depressive Problems Attention Deficit/Hyperactivity Problems
IL6 1.124 1.010; 1.251 0.055 1.118 1.017; 1.230 0.038
TBARS 1.022 1.012; 1.031 < 0.001 1.020 1.012; 1.028 < 0.001
BDNF 1.013 1.005; 1.021 0.006 1.004 0.997; 1.011 0.373
Anxiety Problems Oppositional Defiant Problems
IL6 1.193 1.065; 1.336 0.006 1.092 0.973; 1.225 0.185
TBARS 1.014 1.004; 1.023 0.014 1.020 1.010; 1.029 < 0.001
BDNF 1.005 0.996; 1.014 0.298 1.001 0.993; 1.010 0.771
Somatic Problems Conduct Problems
IL6 1.207 1.031; 1.413 0.036 1.198 1.048; 1.369 0.019
TBARS 1.003 0.991; 1.016 0.681 1.033 1.021; 1.044 0.003
BDNF 1.006 0.995; 1.018 0.355 1.003 0.993; 1.012 0.667
* Adj. p-value: Benjamini Hochberg post hoc corrected p-value.
RR: rate ratio; CI: confidence interval; IL6: interlukin-6; TBARS: thiobarbituric acid-reactive substance; BDNF: brain-derived neurotrophic factor.
doi:10.1371/journal.pone.0160455.t003
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psychopathology constructs are more likely to predict themselves (i.e. homotypic continuity),
whereas some domains are more likely to predict others (i.e. heterotypic continuity). Evidence
indicates that conduct problems are mostly stable over time; oppositional/defiant problems,
instead, are stronger predictors of affective and attentional problems [66, 67]. These developmen-
tal pathways are dynamically influenced by genetic and non-genetic factors [6, 68, 69]. Interest-
ingly, this transition from oppositional problems toward mood/anxiety symptoms seems to be
partially mediated by environmental risk factors [66, 70]. Our data suggest that SED’s relation-
ship with different neurobiological substrates, likely determined by each individual genetic vul-
nerabilities and/or previous or co-occurring exposure to other environmental factors, accounts,
at least partially, to its differential associations with disparate domains of psychopathology.
Nevertheless, the principle of equifinality, which refers to a diversity of pathways leading to same
phenotype, may also apply (62). Low socioeconomic position is frequently correlated with other risk
factors, including, but not limited to, parental mental disorders and exposure to perinatal complica-
tions [11, 71–73]. We recently reported, using data from this same sample, that SED is associated
with parental mental disorders, but that its association with general psychopathology was indepen-
dent and did not interact with familial mental illness (Mansur et al., unpublished data), a finding that
is consistent with other studies [10]. However, we separately documented an interaction between
SED and parental psychopathology on IL6 levels[40], indicating that the results described herein
may not represent an isolated effect of SED. Our sample size and study design does not allow the dis-
entangling of multiple risk factors’ effects, therefore, these findings need to be replicated and refined,
with consideration for reciprocate and interacting associate factors, in larger, prospective samples.
This study has limitations that limit inferences and interpretations of the data. The cross-
sectional design precludes conclusions about causality. It is not possible to determine, based on
our data, whether exposure to SED or alterations in serum biomarkers precede the onset of
psychopathology. We used a cumulative composite of SED, therefore other important determi-
nants of environmental factors impact, such as extent and timing of exposure, were not directly
assessed. Our SED index weighted equally all components. The studied factors are not inter-
changeable and may impact different etiological pathways; it is also possible that different com-
binations may have divergent effects [74, 75]. Moreover, as there are no longitudinal studies
evaluating the markers assessed in this study, there are questions about their stability over
time. We collected the samples in a relatively narrow period of the day; however, it is possible
that the biomarker’s levels were affected by temporal and contextual factors. Nonetheless, our
study also has a number of strengths. Our study population was derived from a large, commu-
nity-based sample, enriched for the presence of psychopathology. We used a multi-informant
clinical evaluation with validated instruments, thus obtaining data directly from parents and
limiting rater and information biases. Finally, we simultaneously assessed a range of dimen-
sional domains of psychopathology, which provides more insight on the diverse effects of SED.
In summary, SED was associated with disparate domains of psychopathology in children, as
well as with increased serum levels of IL6, TBARS and BDNF. In addition, SED was also shown
to moderate the association between IL6, TBARS and BDNF, and mental health problems, sug-
gesting that SED’s different associations with psychopathology are, at least partially, related to
its engagement of different neurobiological pathways. Prospective evaluation of this cohort
may provide further information about the interaction between SED, serum biomarkers, psy-
chopathology, and the onset of psychiatric disorders.
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